Lataa...
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
BACKGROUND: Long-term treatment with antipsychotic agents is indicated for patients with schizophrenia, but treatment is associated with adverse events (AEs) that contribute to medication discontinuation and nonadherence. Understanding drug safety profiles is critical to avoid unwanted side effects....
Tallennettuna:
| Julkaisussa: | Neuropsychiatr Dis Treat |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040316/ https://ncbi.nlm.nih.gov/pubmed/33854317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S301225 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|